Annovis Bio ANVS
NYSE ANVS
$0.82 -0.05 (-5.68%)
As of: Nov 11, 2026 · 9:30 AM EST

Annovis Bio (ANVS) Other non-cash items (2024 - 2026)

Updated

Analysis

Annovis Bio (ANVS) Other non-cash items (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Annovis Bio 37.07 Mn -30.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -986,000.00
Mar 31, 2026 -268,000.00
Dec 31, 2025 296,000.00
Sep 30, 2025 -20,000.00
Jun 30, 2025 140,000.00
Mar 31, 2025 -558,000.00
Dec 31, 2024 -727,001.00
Sep 30, 2024 7.86 Mn
Jun 30, 2024 -4.06 Mn
Mar 31, 2024 -6.70 Mn
API Access

Annovis Bio Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ANVS&period=max&api_key=YOUR_API_KEY